MG
Minas Gerais
Thus, we analyzed the effects of the pandemic on care during prenatal care and delivery by comparing the results of two surveys (one was administered before the pandemic and the other during the pandemic) in public hospitals in Belo Horizonte - Minas Gerais (MG), Brazil.
ObjectiveTo study the COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis (MG).
Myasthenia gravis (MG) is an autoimmune disease characterized by increased dynamic muscleweaknessMyasthenia gravis (MG) is an autoimmune disease characterized by increased dynamic muscleweakness.
Introduction  We previously conducted a survey study in April 2020 at the beginning of the SARS-CoV-2 (COVID-19) pandemic to understand how it affected patients with myasthenia gravis (MG).
Myasthenia gravis (MG) is a rare autoimmune disease that is potentially threatening for patient life.
BackgroundCOVID-19 vaccines are required for individuals with myasthenia gravis (MG), as these patients are more likely to experience severe pneumonia, myasthenia crises, and higher mortality rate.
Abstract Purpose To determine if the Meibomian Gland (MG) secretion quality is associated with symptoms of ocular discomfort, hours of Video Display Terminals (VDT) use, eyelid margin abnormalities, conjunctival hyperemia, and Meibomian Gland Loss Area (MGLA) in a sample of university students.
Le 18 février, les Cercles des médecins généralistes (MG) francophones et les syndicats médicaux envoient un courrier aux ministres de la Santé (il y a en Belgique 9 ministres de la Santé pour les 6 gouvernements : fédéral, communautaires, régionaux) pour attirer leur attention et proposer un plan pour l’implication des médecins généralistes2.